{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:08:57Z","timestamp":1789765737812,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T00:00:00Z","timestamp":1203897600000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1186\/1532-429x-10-12","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T02:15:19Z","timestamp":1203992119000},"page":"12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction"],"prefix":"10.1016","volume":"10","author":[{"given":"Mark A","family":"Tanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Galanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian C","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pibiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Malcolm","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley J","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/1532-429X-10-12_bib1","series-title":"The thalassaemia syndromes","author":"Weatherall","year":"2001"},{"key":"10.1186\/1532-429X-10-12_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1186\/1532-429X-10-12_bib3","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib4","first-page":"1187","article-title":"Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980\u20132004","volume":"91","author":"Telfer","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib5","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta thalassaemia major in the UK: Data from the UK Thalassaemia Register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-12_bib6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"key":"10.1186\/1532-429X-10-12_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J Mol Med"},{"key":"10.1186\/1532-429X-10-12_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1542","article-title":"Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1","volume":"13","author":"Ludwiczek","year":"2007","journal-title":"Nat Med"},{"key":"10.1186\/1532-429X-10-12_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-12_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10976640600698155","article-title":"Myocardial iron loading in patients with thalassaemia major on deferoxamine chelation","volume":"8","author":"Tanner","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-10-12_bib11","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of the effect of deferiprone or deferoxamine on myocardial iron and function in beta-thalassemia major","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-12_bib12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-10-12_bib13","first-page":"1309","article-title":"Combined therapy with deferiprone and desferrioxamine in thalassemia major","volume":"90","author":"Origa","year":"2005","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","article-title":"Combined therapy with deferiprone and desferrioxamine","volume":"103","author":"Wonke","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-12_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1067\/mlc.2001.116487","article-title":"Exploring the \u201ciron shuttle\u201d hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture","volume":"138","author":"Link","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1186\/1532-429X-10-12_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","article-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-12_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-12_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmri.10396","article-title":"Interscanner reproducibility of cardiovascular magnetic resonance in the early diagnosis of myocardial iron overload","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-12_bib19","first-page":"1388","article-title":"Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron","volume":"91","author":"Tanner","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-10-12_bib21","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehl336","article-title":"Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance","volume":"27","author":"Maceira","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1186\/1532-429X-10-12_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jmri.20915","article-title":"Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron","volume":"25","author":"Westwood","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-12_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2141.2001.03195.x","article-title":"Practical management of iron overload","volume":"115","author":"Porter","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-12_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jmri.10332","article-title":"A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-12_bib25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jmri.20929","article-title":"Black-blood T2* technique for myocardial iron measurement in thalassemia","volume":"25","author":"He","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-12_bib26","series-title":"Braunwald's Heart Disease: A textbook of cardiovascular medicine","first-page":"335","article-title":"Cardiovascular Magnetic Resonance","author":"Pennell","year":"2005"},{"key":"10.1186\/1532-429X-10-12_bib27","first-page":"250","article-title":"Survival following the onset of iron-induced cardiac disease in thalassaemia major","volume":"86","author":"Olivieri","year":"1995","journal-title":"Blood (Abstract)"},{"key":"10.1186\/1532-429X-10-12_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.1998.tb10481.x","article-title":"Diagnosis and management of iron-induced heart disease in Cooley's anemia","volume":"850","author":"Jessup","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1186\/1532-429X-10-12_bib29","first-page":"658","article-title":"Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients","volume":"30","author":"Tamary","year":"1994","journal-title":"Isr J Med Sci"},{"key":"10.1186\/1532-429X-10-12_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.1990.tb24316.x","article-title":"Current treatment of Cooley's anemia. Intravenous chelation therapy","volume":"612","author":"Cohen","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1186\/1532-429X-10-12_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2003-08-2841","article-title":"Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major","volume":"104","author":"Davis","year":"2004","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-12_bib32","first-page":"1309","article-title":"Combined therapy with deferiprone and desferrioxamine in thalassemia major","volume":"90","author":"Origa","year":"2005","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcmd.2005.11.002","article-title":"Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial","volume":"36","author":"Kattamis","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1186\/1532-429X-10-12_bib34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00277-003-0820-0","article-title":"Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassaemia major","volume":"83","author":"Wu","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1186\/1532-429X-10-12_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0609.2004.00335.x","article-title":"reversal of heart failure in thalassaemia major by combined chelation therapy: a case report","volume":"74","author":"Tsironi","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1186\/1532-429X-10-12_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejheart.2006.08.006","article-title":"Effects of combined deferiprone and desferrioxamine iron chelating therapy in beta-thalassemia major end-stage heart failure: a case report","volume":"9","author":"Porcu","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"Supplement 2","key":"10.1186\/1532-429X-10-12_bib37","first-page":"11","article-title":"Mortality and morbidity in thalassaemia with conventional treatment. In Proceedings of the third international conference on bone marrow transplantation in thalassaemia","volume":"19","author":"Piga","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1186\/1532-429X-10-12_bib38","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassaemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib39","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-12_bib40","first-page":"1241","article-title":"A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia","volume":"91","author":"Galanello","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-12_bib41","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1186\/1532-429X-10-12_bib42","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-12_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1186\/1532-429X-10-12_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/03630260600642542","article-title":"Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassaemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*","volume":"30","author":"Kolnagu","year":"2006","journal-title":"Hemoglobin"},{"key":"10.1186\/1532-429X-10-12_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000089475","article-title":"Development of thalassemic cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine","volume":"115","author":"Anderson","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1186\/1532-429X-10-12_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1186\/1532-429X-10-12_bib47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and deaths","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1532-429X-10-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:08:36Z","timestamp":1761095316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664723012292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1097664723012292"],"URL":"https:\/\/doi.org\/10.1186\/1532-429x-10-12","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/1532-429X-10-12","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"12"}}